Dr Agarwal's Eye Hospital Ltd
BSE:526783
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 622.95
5 535.7002
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dr Agarwal's Eye Hospital Ltd
Accounts Receivables
Dr Agarwal's Eye Hospital Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
Accounts Receivables
â‚ą129.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
||
Thyrocare Technologies Ltd
NSE:THYROCARE
|
Accounts Receivables
â‚ą434.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
||
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
Accounts Receivables
â‚ą901m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
||
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
Accounts Receivables
â‚ą149.5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
||
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
Accounts Receivables
â‚ą1.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
||
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
Accounts Receivables
â‚ą1.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
Dr Agarwal's Eye Hospital Ltd
Glance View
Dr. Agarwal's Eye Hospital Ltd. operates as an eye hospital, which engages in the provision of eye care solutions. The company is headquartered in Chennai, Tamil Nadu. The firm provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti vegf, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and paediatric ophthalmology. The company also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The firm provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Puducherry, Gujarat, Rajasthan, Madhya Pradesh and Andaman.
See Also
What is Dr Agarwal's Eye Hospital Ltd's Accounts Receivables?
Accounts Receivables
129.3m
INR
Based on the financial report for Jun 30, 2024, Dr Agarwal's Eye Hospital Ltd's Accounts Receivables amounts to 129.3m INR.
What is Dr Agarwal's Eye Hospital Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
8%
Over the last year, the Accounts Receivables growth was 28%. The average annual Accounts Receivables growth rates for Dr Agarwal's Eye Hospital Ltd have been 14% over the past three years , 8% over the past five years , and 8% over the past ten years .